| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206; and
Departments of Immunology, Pediatrics, and Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, CO 80262
Activation of the T lymphocyte induces dramatic cytoskeletal changes, and there is increasing evidence that disruption of the cytoskeleton inhibits early and late events of T cell signal transduction. However, relatively little is known about the signaling molecules involved in activation-induced cytoskeletal rearrangement. The rho family of small GTP-binding proteins, which include rho, rac, and cdc42, regulates the cytoskeleton and coordinates various cellular functions via their many effector targets. In prior studies, the Clostridium botulinum toxin C3 exoenzyme has been used to ADP-ribosylate and inactivate rho. In this study, we demonstrate that treatment of T cells with C3 exoenzyme inhibits IL-2 transcription following ligation of the TCR. Inhibition of IL-2 expression correlated with loss of sustained increase in [Ca+2]i and mitogen activated protein kinase (MAPK/Erk) activity, but not with activation of the tyrosine kinase, lck. These findings are the first to show that ADP-ribosylation of rho by C3 ribosyltransferase (exoenzyme) inhibits IL-2 production due, in part, to the requirement for sustained calcium influx and MAPK activation after Ag receptor ligation.
This article has been cited by other articles:
|
|
 |
|
  Y. Xu, J. Li, G. D. Ferguson, F. Mercurio, G. Khambatta, L. Morrison, A. Lopez-Girona, L. G. Corral, D. R. Webb, B. L. Bennett, et al. Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases Blood, July 9, 2009; 114(2): 338 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Su, N. Lineberry, Y. Huh, L. Soares, and C. G. Fathman A Novel E3 Ubiquitin Ligase Substrate Screen Identifies Rho Guanine Dissociation Inhibitor as a Substrate of Gene Related to Anergy in Lymphocytes J. Immunol., December 1, 2006; 177(11): 7559 - 7566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Mallat, A. Gojova, V. Sauzeau, V. Brun, J.-S. Silvestre, B. Esposito, R. Merval, H. Groux, G. Loirand, and A. Tedgui Rho-Associated Protein Kinase Contributes to Early Atherosclerotic Lesion Formation in Mice Circ. Res., October 31, 2003; 93(9): 884 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-L. Tharaux, R. C. Bukoski, P. N. Rocha, S. D. Crowley, P. Ruiz, C. Nataraj, D. N. Howell, K. Kaibuchi, R. F. Spurney, and T. M. Coffman Rho Kinase Promotes Alloimmune Responses by Regulating the Proliferation and Structure of T Cells J. Immunol., July 1, 2003; 171(1): 96 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Lou, D. D. Billadeau, D. N. Savoy, R. A. Schoon, and P. J. Leibson A Role for a RhoA/ROCK/LIM-Kinase Pathway in the Regulation of Cytotoxic Lymphocytes J. Immunol., November 15, 2001; 167(10): 5749 - 5757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Adachi, R. Vita, S. Sannohe, S. Stafford, R. Alam, H. Kayaba, and J. Chihara The Functional Role of Rho and Rho-Associated Coiled-Coil Forming Protein Kinase in Eotaxin Signaling of Eosinophils J. Immunol., October 15, 2001; 167(8): 4609 - 4615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, E. Azuma, M. Ido, M. Hirayama, Q. Jiang, S. Iwamoto, T. Kumamoto, H. Yamamoto, M. Sakurai, and Y. Komada A Pivotal Role of Rho GTPase in the Regulation of Morphology and Function of Dendritic Cells J. Immunol., October 1, 2001; 167(7): 3585 - 3591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. S. Kabarowski, J. D. Feramisco, L. Q. Le, J. L. Gu, S.-W. Luoh, M. I. Simon, and O. N. Witte Direct genetic demonstration of Galpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement PNAS, October 24, 2000; 97(22): 12109 - 12114. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
